VK2735
Asset
Activates GLP-1 and GIP receptors to regulate appetite and glucose metabolism.
- Stage
- Phase 3
- Modality
- Peptide
- Target
- Insulin/IGF-1 signalling
- 1
- Indication
- 2
- Trials
- 1
- Developer
Indications
1Obesity
Phase 3, prnewswire.com, 14 Oct 2026
In the full profile
- Targets and what it contains4
- Owner and partners1
- Trials2
- Evidence for its targets5
- Competitors12
- Aging relevance1
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.